IL-2 and IFN-γ levels in the rEg.P29 group increased statistically compared with that in PBS or FCA groups (P < 0.01) at week 6 (2 weeks after the boost immunization) and then sequentially increased at week 9 (1 week after the infection) (Fig. 4a and b). The gene discussed is IFNG; the disease is infection.